Clinical Trials on Small Lymphocytic Leukemia
Total 15818 results
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyWithdrawnLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterRoche Pharma AGCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedChronic Lymphocytic LeukemiaFrance
-
Afexa Life Sciences IncWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Genta IncorporatedCompletedChronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompletedChronic Lymphocytic LeukemiaUnited States
-
Institut Paoli-CalmettesCompletedChronic Lymphocytic LeukemiaFrance
-
KineMedChronic Lymphocytic Leukemia Research ConsortiumCompletedChronic Lymphocytic LeukemiaUnited States
-
Santaris Pharma A/SCompletedChronic Lymphocytic LeukemiaFrance, Denmark, United Kingdom, United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Ascenta TherapeuticsCompletedChronic Lymphocytic LeukemiaUnited States
-
Charite University, Berlin, GermanyDeutsche Klinik fuer Diagnostik; University Hospital Carl Gustav CarusUnknownChronic Lymphocytic LeukemiaGermany
-
French Innovative Leukemia OrganisationCompletedLeukemia, Lymphocytic, Chronic
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
National Cancer Institute (NCI)TerminatedLarge Granular Lymphocytic Leukemia | LGL LeukemiaUnited States
-
University of UtahNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Small Lymphocytic Lymphoma | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia and other conditionsUnited States
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
Nanfang Hospital of Southern Medical UniversityNot yet recruitingChronic Lymphocytic Leukemia
-
National Taiwan University HospitalRecruitingChronic Lymphocytic LeukemiaTaiwan
-
Institute of Hematology & Blood Diseases HospitalRecruitingChronic Lymphocytic LeukemiaChina
-
AbbVieCompletedChronic Lymphocytic LeukemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States
-
University of UlmAbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study GroupCompletedLeukemia, Lymphocytic, ChronicGermany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Gruppo Italiano Malattie EMatologiche dell'AdultoERIC GroupCompleted
-
Grupo Espanol de trasplantes hematopoyeticos y...GlaxoSmithKlineCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieMundipharma Pte Ltd.CompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
ItalfarmacoTerminatedChronic Lymphocytic LeukemiaItaly
-
German CLL Study GroupCelgeneCompletedChronic Lymphocytic LeukemiaGermany
-
Memgen, LLCUniversity of California, San Diego; The Leukemia and Lymphoma SocietyCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
Boehringer IngelheimCompletedLeukemia, Lymphocytic, Chronic, B-CellGermany, Belgium, France
-
German CLL Study GroupGilead Sciences; Novartis PharmaceuticalsCompletedChronic Lymphocytic LeukemiaGermany
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLeukemia | Chronic Lymphocytic Leukemia | Lymphocytic LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLeukemiaUnited States, Canada
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaArgentina
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, Hungary, Belgium, United Kingdom, France, Australia, Turkey, Croatia, Italy, Poland, Canada, Greece, Czechia, Ireland, Russian Federation, Spain, Portugal, Romania
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Pirogov Russian National Research Medical UniversityUnknownChronic Lymphocytic LeukemiaRussian Federation